Active ingredientOndansetronCat. No. P-O023-001CAS 99614-02-5Family · Pharmaceutical analytical standards
Ondansetron
A selective serotonin 5-HT3 receptor antagonist developed in London in the mid-1980s and approved in the United States in 1991. It prevents nausea and vomiting caused by chemotherapy and surgery and is on the WHO List of Essential Medicines. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Chemotherapy makes enterochromaffin cells in the gut release serotonin, which stimulates the vagus nerve and triggers the vomiting reflex: ondansetron works mainly by blocking this signal in the periphery.
Go to the active ingredient →Active ingredientOndansetronCat. No. P-O023-001CAS 99614-02-5
Active ingredientOndansetron HClCat. No. P-O023-002CAS 99614-01-4
Active ingredientOndansetron Hydrochloride DihydrateCat. No. P-O023-003CAS 103639-04-9
Pharmacopoeial impurityImidazoleCat. No. P-O023-004CAS 288-32-4
Pharmacopoeial impurityOndansetron EP Impurity A HydrochlorideCat. No. P-O023-005CAS 119812-29-2
Pharmacopoeial impurityOndansetron EP Impurity ACat. No. P-O023-006CAS 153139-56-1
Pharmacopoeial impurityOndansetron EP Impurity BCat. No. P-O023-007CAS 1076198-52-1
Pharmacopoeial impurityOndansetron EP Impurity CCat. No. P-O023-008CAS 27387-31-1
Pharmacopoeial impurityOndansetron EP Impurity DCat. No. P-O023-009CAS 99614-64-9
Pharmacopoeial impurityOndansetron EP Impurity FCat. No. P-O023-010CAS 693-98-1
Pharmacopoeial impurityOndansetron EP Impurity GCat. No. P-O023-011CAS 99614-03-6
Pharmacopoeial impurityOndansetron EP Impurity HCat. No. P-O023-012CAS 99614-14-9
Isotopically labelledOndansetron Related Compound A (USP)-13C-d3Cat. No. P-O023-013
Isotopically labelledOndansetron Related Compound A (USP)-d6Cat. No. P-O023-014
Isotopically labelledOndansetron-13C-d3Cat. No. P-O023-015CAS 2699607-85-5
Impurity1,2,3,9-Tetrahydro-4H-carbazol-4-oneCat. No. P-O023-018CAS 15128-52-6
ImpurityOndansetron Impurity 1Cat. No. P-O023-019CAS 1216890-42-4
Impurity6-Hydroxy OndansetronCat. No. P-O023-020CAS 110708-17-3
Impurity6-Hydroxy Ondansetron HClCat. No. P-O023-021
ImpurityOndansetron Impurity 2Cat. No. P-O023-022CAS 1432682-04-6
Impurity6-Methyldi(ondansetron-3-de(1,2-dimethyl-1H-imidazole))Cat. No. P-O023-023CAS 1365727-07-6
Impurity7-Hydroxy Ondansetron HClCat. No. P-O023-024
Impurity8-Hydroxy OndansetronCat. No. P-O023-025CAS 126671-71-4
ImpurityN-Desmethyl ondansetron maleateCat. No. P-O023-026CAS 99614-15-0
ImpurityOndansetron 1-Hydroxy Impurity (Mixture of Diastereomers)Cat. No. P-O023-027
ImpurityOndansetron Impurity 3Cat. No. P-O023-028CAS 1365727-09-8
ImpurityOndansetron Oxo ImpurityCat. No. P-O023-030No product matches your search.
EDQM standards 9
The official European Pharmacopoeia standards for this family.
Reference substanceImidazole CRSEDQM code I0086000Family OndansetronReference substanceOndansetron hydrochloride dihydrate CRSEDQM code Y0000218Family OndansetronImpurityOndansetron impurity A CRSEDQM code Y0001345Family OndansetronImpurityOndansetron impurity D CRSEDQM code Y0000195Family OndansetronImpurityOndansetron impurity E CRSEDQM code Y0001326Family OndansetronImpurityOndansetron impurity F CRSEDQM code Y0001320Family OndansetronImpurityOndansetron impurity G CRSEDQM code Y0001346Family OndansetronNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.